Overcoming leukemia heterogeneity by combining T cell engaging bispecific antibodies

BACKGROUND: Leukemia represents about 5% of all human cancers. Despite advances in therapeutics, a substantial number of patients succumb to the disease. Several subtypes of leukemia are inherently more resistant to treatment despite intensive chemotherapy or targeted therapy. METHODS: Here we descr...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Immunother Cancer
Hlavní autoři: Hoseini, Sayed Shahabuddin, Espinosa-Cotton, Madelyn, Guo, Hong-fen, Cheung, Nai-Kong V
Médium: Artigo
Jazyk:Inglês
Vydáno: BMJ Publishing Group 2020
Témata:
Basic Tumor Immunology
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7689592/
https://ncbi.nlm.nih.gov/pubmed/33239418
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/jitc-2020-001626
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky